Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Devine

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|March 24, 2011
Titanium-catalyzed esterification and transesterification reactions facilitated using microwave heatingWilliam G Devine, Nicholas E Leadbeater, Linda A Jacob
Scientific Reports|April 19, 2016
Fine-tuning of macrophage activation using synthetic rocaglate derivativesBidisha Bhattacharya, Sujoy Chatterjee, William G Devine, et al.
Cell Chemical Biology|September 15, 2019
Amidino-Rocaglates: A Potent Class of eIF4A InhibitorsJennifer Chu, Wenhan Zhang, Regina Cencic, et al.
Scientific Reports|February 6, 2019
Oxo-aglaiastatin-Mediated Inhibition of Translation InitiationRayelle Itoua Maïga, Regina Cencic, Jennifer Chu, et al.
Molecular Cancer Therapeutics|June 22, 2022
Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell RadiosensitivityStacey L Lehman, Theresa Wechsler, Kayla Schwartz, et al.
ACS Infectious Diseases|January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African TrypanosomiasisWilliam G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Cell Reports|February 27, 2020
Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4FJennifer Chu, Wenhan Zhang, Regina Cencic, et al.
Leukemia|June 8, 2019
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomasXuan Zhang, Chengfeng Bi, Ting Lu, et al.
Science Translational Medicine|May 12, 2017
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myelomaSalomon Manier, Daisy Huynh, Yu J Shen, et al.
RSC Medicinal Chemistry|January 22, 2021
Structure-property studies of an imidazoquinoline chemotype with antitrypanosomal activityDana M Klug, Rosario Diaz-Gonzalez, Travis J DeLano, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|March 24, 2011
Titanium-catalyzed esterification and transesterification reactions facilitated using microwave heatingWilliam G Devine, Nicholas E Leadbeater, Linda A Jacob
Scientific Reports|April 19, 2016
Fine-tuning of macrophage activation using synthetic rocaglate derivativesBidisha Bhattacharya, Sujoy Chatterjee, William G Devine, et al.
Cell Chemical Biology|September 15, 2019
Amidino-Rocaglates: A Potent Class of eIF4A InhibitorsJennifer Chu, Wenhan Zhang, Regina Cencic, et al.
Scientific Reports|February 6, 2019
Oxo-aglaiastatin-Mediated Inhibition of Translation InitiationRayelle Itoua Maïga, Regina Cencic, Jennifer Chu, et al.
Molecular Cancer Therapeutics|June 22, 2022
Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell RadiosensitivityStacey L Lehman, Theresa Wechsler, Kayla Schwartz, et al.
ACS Infectious Diseases|January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African TrypanosomiasisWilliam G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Cell Reports|February 27, 2020
Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4FJennifer Chu, Wenhan Zhang, Regina Cencic, et al.
Leukemia|June 8, 2019
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomasXuan Zhang, Chengfeng Bi, Ting Lu, et al.
Science Translational Medicine|May 12, 2017
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myelomaSalomon Manier, Daisy Huynh, Yu J Shen, et al.
RSC Medicinal Chemistry|January 22, 2021
Structure-property studies of an imidazoquinoline chemotype with antitrypanosomal activityDana M Klug, Rosario Diaz-Gonzalez, Travis J DeLano, et al.
Pageof 2